Refile: BRIEF-Neurovive says clinical development project KL1333 gets positive opinion on European orphan drug designation
08/11/2017 10:20
(Fixes headline in original story)
Nov 8 (Reuters) - Neurovive Pharmaceutical AB NVP.ST
* Neurovive's clinical development project KL1333 receives
positive opinion on european orphan drug designation
Source text for Eikon: ID:nWkr74DYDg
Further company coverage: NVP.ST
(Stockholm Newsroom)
((stockholm.newsroom@thomsonreuters.com; +46)(0)(8-700 10 10;))